Related Experiment Videos

Clinical factors affecting the efficacy of vancomycin in methicillin-resistant Staphylococcus aureus pneumonia

N Shimazaki1, H Hayashi, K Umeda

  • 1Department of Pharmacy, International Goodwill Hospital, Yokohama, Kanagawa, Japan. shimazaki-nobuo@shinzen.jp

International Journal of Clinical Pharmacology and Therapeutics
|July 24, 2010
PubMed
Abstract

Insights

Underlying malignancy and parenteral nutrition significantly impact survival in patients treated with vancomycin (VCM) for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. These factors, related to nutrition and immunity, were more critical than VCM pharmacokinetics or pneumonia severity.

Area of Science:

  • Infectious Diseases
  • Clinical Pharmacy
  • Critical Care Medicine

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of hospital-acquired infections, particularly pneumonia.
  • MRSA pneumonia in compromised hosts has high mortality and is challenging to treat effectively.
  • Vancomycin (VCM) is a primary treatment for MRSA infections, but its efficacy can vary.

Purpose of the Study:

  • To identify factors influencing the effectiveness of vancomycin (VCM) therapy for methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.
  • To analyze patient background, VCM pharmacokinetics, and pneumonia severity in relation to treatment outcomes.
  • To determine predictors of survival in patients with MRSA pneumonia receiving VCM.

Main Methods:

  • Retrospective investigation of 40 patients treated with VCM for MRSA pneumonia between January 2003 and March 2008.
  • Evaluation of pneumonia severity, VCM pharmacokinetic parameters, clinical improvement, and patient data.
  • Multivariate logistic regression analysis to identify significant factors affecting 30-day mortality.

Main Results:

  • The 30-day mortality rate was 15.0% (6 out of 40 patients).
  • Underlying malignancy (OR = 22.3) and parenteral nutrition (OR = 12.6) were significant predictors of mortality.
  • Vancomycin pharmacokinetic parameters and pneumonia severity did not significantly impact survival.

Conclusions:

  • Underlying malignancy and parenteral nutrition are critical factors affecting survival in MRSA pneumonia patients treated with VCM.
  • These factors highlight the importance of nutritional status and immune system support in managing severe MRSA infections.
  • Further research may focus on optimizing supportive care alongside VCM therapy.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...